Bortezomib (PS-341): Mechanistic Insights into Reversible...

2025-09-18

Explore the molecular mechanisms by which Bortezomib (PS-341), a potent reversible proteasome inhibitor, orchestrates apoptosis in cancer cells. This article discusses recent findings on proteasome-regulated cellular processes, highlighting the intersection of proteasome inhibition and emerging cell death pathways in oncology research.

Ophiobolin B

2025-09-18

NHS-LC-LC-Biotin

2025-09-17

WEHI-539

2025-09-16

1A-116

2025-09-13

Anti-PTPRCCD45 Antibody (Apamistamab)

2025-09-13

Anti-CXCL11 Rabbit Monoclonal Antibody

2025-09-12

16-Ketoestradiol

2025-09-12

Dimaprit dihydrochloride

2025-09-11

H-Ser-His-OH

2025-09-10

Propargyl-PEG2-acid

2025-09-10

MS170

2025-09-09

Diosbulbin B

2025-09-09

Thioridazine HCl

2025-09-08

JSH-150

2025-09-05